Holger Wesche, Chief Scientific Officer at Harpoon Therapeutics, Inc. (HARP), sold 10,000 shares at $20.41 ($204K) on 2021-04-01, disclosed to the SEC on 2021-04-05.
Open-market sale of $204k HARP by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.41 | 9,500 | $194K | 94.8% |
| 2 | $21.14 | 500 | $11K | 5.2% |
| Total | $20.45 avg | 10,000 | $204K | 100% |
| Filing → |
| HARP | SELL | 2020-10-05 | $163K | — | Filing → |
| HARP | SELL | 2020-07-02 | $162K | — | Filing → |
| HARP | SELL | 2020-05-13 | $20K | — | Filing → |